The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo

  • Ann N Y Acad Sci. 1998 Dec 15;861:270-1. doi: 10.1111/j.1749-6632.1998.tb10219.x.
L M Gaster  1 ,  P Ham ,  G F Joiner ,  F D King ,  K R Mulholland ,  P A Wyman ,  J J Hagan ,  G W Price ,  C Roberts ,  C Routledge ,  J Selkirk ,  P D Slade ,  D N Middlemiss
Affiliations
  • 1. SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, UK. [email protected]
Products